Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dentsply Sirona (XRAY) Research & Development (2020 - 2025)

Dentsply Sirona (XRAY) has disclosed Research & Development for 6 consecutive years, with $37.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Research & Development fell 7.5% year-over-year to $37.0 million, compared with a TTM value of $150.0 million through Sep 2025, down 9.64%, and an annual FY2023 reading of $184.0 million, up 5.75% over the prior year.
  • Research & Development was $37.0 million for Q3 2025 at Dentsply Sirona, roughly flat from $37.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $49.0 million in Q4 2021 and bottomed at $36.0 million in Q1 2025.
  • Average Research & Development over 5 years is $42.3 million, with a median of $42.5 million recorded in 2021.
  • The sharpest move saw Research & Development surged 115.0% in 2021, then decreased 16.33% in 2024.
  • Year by year, Research & Development stood at $49.0 million in 2021, then dropped by 12.24% to $43.0 million in 2022, then changed by 0.0% to $43.0 million in 2023, then fell by 6.98% to $40.0 million in 2024, then dropped by 7.5% to $37.0 million in 2025.
  • Business Quant data shows Research & Development for XRAY at $37.0 million in Q3 2025, $37.0 million in Q2 2025, and $36.0 million in Q1 2025.